Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05612399 · ClinicalTrials.gov registry record
Precision Analgesia for Cardiac Surgery
A clinical trial, sponsored by Kathirvel Subramaniam.
- Not yet
- Registry status
- 400
- Enrollment target
NCT05612399: Clinical Trial study, sponsored by Kathirvel Subramaniam.
NCT05612399 is a clinical trial that has not yet begun recruiting, run by Kathirvel Subramaniam. The registered enrollment target is 400 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05612399 has not yet begun recruiting, sponsored by Kathirvel Subramaniam.
- NOT YET RECRUITING
- Registry status
- 400 participants
- Enrollment target
Study Summary
The proposed research is an important extension of an ongoing perioperative personalized analgesia and intravenous opioid pharmacogenetic research. This research focuses on two of the most commonly used oral opioid analgesics, oxycodone, and methadone in elderly adults undergoing cardiac surgery.
Primary Outcome
Respiratory depression will be measured with binary yes/no responses obtained either via self-report from the patient or reported by the clinical care staff.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2026-05 |
| Est. Completion | 2026-12-01 |
What is known before NCT05612399 opens enrollment
NCT05612399 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT05612399 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05612399 about?
NCT05612399 is a clinical study titled "Precision Analgesia for Cardiac Surgery". The proposed research is an important extension of an ongoing perioperative personalized analgesia and intravenous opioid pharmacogenetic research. This research focuses on two of the most commonly used oral opioid analgesics, oxycodone, and methadone in elderly adults undergoing cardiac surgery.
What is the current status of trial NCT05612399?
This trial is currently not yet recruiting. The enrollment target is 400 participants. The study started on 2026-05. Estimated completion is 2026-12-01.
Who is sponsoring clinical trial NCT05612399?
This trial is sponsored by Kathirvel Subramaniam, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia